Načítá se...
Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery
OBJECTIVES: To evaluate the efficacy of Human Urinary Kallidinogenase (HUK) for secondary stroke prevention in the treatment of acute ischemic stroke (AIS) patients. MATERIALS AND METHODS: In this retrospective study, from October 2016 to June 2017, 300 consecutive AIS patients were registered in ou...
Uloženo v:
| Vydáno v: | Brain Behav |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6085914/ https://ncbi.nlm.nih.gov/pubmed/30030910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1033 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|